ArticleBMC pulmonary medicine2026

Mepolizumab initiation by day 30 and glucocorticoid exposure in newly diagnosed EGPA: a single-center 30-day landmark cohort study.

Shota Kaburaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.